PSMA-PET-CT May Allow Some Men to Skip Prostate Biopsy Frederik Joelving June 30, 2026

https://www.medscape.com/viewarticle/psma-pet-ct-may-allow-some-men-skip-prostate-biopsy-2026a1000m68?ecd=WNL_trdalrt_pos1_ous_260701_etid8469101&uac=148436CN&impID=8469101 Prostate-specific membrane antigen (PSMA)-PET is already a standard imaging tool in prostate cancer treatment. Now, a phase 3 clinical trial suggests the imaging modality may also help determine which men can safely avoid prostate biopsy during the diagnostic workup.